Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35. 2007

Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.

Although protein kinase Cdk5-p35 is important in many aspects of the development and function of the central nervous system, relatively little is known about its regulation. In the present study, we examined the relationship between the association of this kinase with membranes and its activity in perinatal and adult rat brains. Cdk5-p35 in perinatal brain exhibited higher activity than that found in adult tissue. Gel filtration chromatography revealed that a portion of Cdk5-p35 from fetal brain occurred as a soluble complex, whereas Cdk5-p35 in adult brain occurred predominantly as a membrane-bound complex. Furthermore, soluble Cdk5-p35 in perinatal brain displayed elevated kinase activity, whereas membrane-bound Cdk5-p35 was highly active only in the presence of detergent. This more active soluble form of Cdk5-p35 correlated to a form in which p35 was phosphorylated, whereas the less active membrane-bound form of Cdk5 correlated to the dephosphorylated form of p35, as evidenced by a downward shift in electrophoretic mobility. Cdk5 activity and transition from soluble to membrane-associated compartments could be modulated by conditions that affected the phosphorylation or dephosphorylation of p35. For example, dephosphorylation of p35 in brain extracts was suppressed by selective inhibition of protein phosphatase-1. Together, these results suggest that the kinase activity of Cdk5-p35 is regulated through its association with membranes, which in turn is under the control of Cdk5-dependent phosphorylation and protein phosphatase-1-dependent dephosphorylation of p35.

UI MeSH Term Description Entries
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000077546 Roscovitine A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent. (2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol,2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine,CYC 202,CYC-202,CYC202,R-roscovitine,Seliciclib,R roscovitine

Related Publications

Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
January 2000, Methods in enzymology,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
July 2003, FEBS letters,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
December 2001, The Journal of biological chemistry,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
April 2005, Journal of neurochemistry,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
April 2000, Current biology : CB,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
April 2015, Chemistry & biology,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
February 2016, Amino acids,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
May 2005, Biochemical and biophysical research communications,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
May 2012, Journal of neurochemistry,
Ko Sato, and Ying-Shan Zhu, and Taro Saito, and Kensuke Yotsumoto, and Akiko Asada, and Masato Hasegawa, and Shin-ichi Hisanaga
July 2011, Molecular pain,
Copied contents to your clipboard!